Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001055726-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-28 | 2025-02-26 | INO | Shea Jacqueline Elizabeth | CEO, Dir | F - Tax | $1.98 | -11.6K | 37.0K | -24% | -$22.9K |
| DM | 2025-02-28 | 2025-02-26 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | — | +24.5K | 55.6K | +79% | — |
| DM | 2025-02-28 | 2025-02-26 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | $0.00 | -24.5K | 0 | -100% | $0 |
| DM | 2025-02-28 | 2025-02-27 | INO | Shea Jacqueline Elizabeth | CEO, Dir | A - Grant | $0.00 | +190.8K | 85.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-26 | F | D | 9,088 | $1.98 | 46,550 | D | — | — | (F4) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein. |
| 2 | Common | Common Stock | 2025-02-26 | F | D | 2,493 | $1.98 | 37,006 | D | — | — | (F2) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 3 | Common | Common Stock | 2025-02-26 | M | A | 5,852 | — | 39,499 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Common | Common Stock | 2025-02-26 | M | A | 18,632 | — | 55,638 | D | — | — | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 5 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 18,632 | $0.00 | 37,263 | D | — · — to — | 18,632 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 6 | Derivative | Common Stock Option | 2025-02-27 | A | A | 105,649 | $0.00 | 105,649 | D | $1.94 · 2025-02-27 to 2035-02-27 | 105,649 Common Stock | (F5) The vesting schedule for the 105,649 options is as follows: 52,825 shares vested on February 27, 2025 and 52,824 shares will vest on February 26, 2026. |
| 7 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 5,852 | $0.00 | 0 | D | — · — to — | 5,852 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 8 | Derivative | Restricted Stock Unit | 2025-02-27 | A | A | 85,201 | $0.00 | 85,201 | D | — · — to — | 85,201 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 is as follows: 28,401 shares will vest on February 26, 2026; 28,400 shares will vest on February 26, 2027; and 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |